Brussels: Among the scientists who depend on European money, a single acronym has become shorthand for an anxious year. They call the next research programme FP10, the successor due to take over once the current Horizon Europe scheme runs its course at the end of the decade. What that programme looks like, and crucially who decides where its billions go, has turned into one of the most charged debates in European science.
The worry is not about the headline figure, though researchers would dearly like it to grow rather than shrink. It is about architecture. The Commission has been weighing whether to pull research funding into a much larger pot aimed at competitiveness, a single instrument that would bundle science, industry and strategic technology together and steer the money toward whatever Europe most needs to build. The promise is coherence. Instead of programmes that barely speak to one another, the bloc would have one lever to pull when it wanted to back batteries, chips, clean fuels or defence technology.
To many in the laboratories, that promise sounds like a threat. The crown jewel of European research funding is the European Research Council, which hands grants to individual scientists purely on the quality of their ideas, with no requirement that the work lead anywhere useful any time soon. Some of the continent’s most important discoveries have come from exactly this kind of curiosity-driven work, the sort no industrial planner would have commissioned. Fold that money into a fund built around competitiveness and near-term payoff, researchers fear, and the patient, unglamorous science that feeds everything else will be the first thing squeezed.
There is a deeper principle at stake than any single grant line. Basic research is a bet on questions whose answers cannot be known in advance, and on people whose best work may come decades after their first funding. A system that asks every euro to justify itself against an industrial roadmap risks crowding out the unpredictable breakthroughs that made the bet worth making. Defenders of the current model argue that the independence of the funding is not a bureaucratic nicety but the whole point, the firewall that keeps science from becoming an arm of industrial policy.
The other side of the argument deserves a fair hearing. Europe has a long and painful record of brilliant research that someone else turned into products and profits. Champions of consolidation say the continent can no longer afford to fund discovery generously and then watch the commercial value migrate to other shores. A fund that links the laboratory to the factory floor, they argue, is exactly what a bloc serious about competing with larger rivals should build. The question is whether you can do that without strangling the open-ended science that gives industry something worth scaling in the first place.
For now the scientific community is mobilising with unusual energy. University networks, learned academies and Nobel laureates have signed open letters insisting that any future programme keep a standalone, generously funded pillar for fundamental research, governed by scientists rather than political priorities. They want the European Research Council protected by name and by budget, not merely promised goodwill. Negotiations over the next budget will run for many months, and the researchers know how these things go. Fine words about excellence are easy to write into a preamble. What they are watching for is whether the independence survives contact with the line items, and whether Europe still trusts its scientists to chase questions whose value no one can yet measure.
